J&J Requests FDA Greenlight for Booster Shot

Johnson & Johnson says a 2nd dose of its vaccine increases immune response to 94% and is now asking the FDA for emergency approval of a booster shot

Washington, D.C. (Tuesday, October 5, 2021) – Johnson and Johnson is requesting emergency approval from the Food and Drug Administration for its COVID booster shot.

The submission today included new data showing the shot increases protection from the virus up to 94 percent for people 18 and older.  The FDA has scheduled meetings of its expert advisory committee for October 14th and 15th to discuss whether to grant the request.

Some 15 million Americans have been vaccinated with the one shot Johnson and Johnson vaccine. J&J says the best immune response for its vaccine happens when a booster is administered at least six months after vaccination.